Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eagle Pharmaceuticals (NQ: EGRX ) 4.530 +0.550 (+13.82%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Eagle Pharmaceuticals < Previous 1 2 3 4 5 6 Next > Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Eagle Pharma Broadens Acute Care Portfolio With Equity Stake In Respiratory Depression Player August 09, 2022 Via Benzinga Eagle Pharmaceuticals: Q2 Earnings Insights August 09, 2022 Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings Eagle Pharmaceuticals... Via Benzinga Stocks That Hit 52-Week Lows On Friday July 22, 2022 During Friday's session, 61 companies made new 52-week lows. Via Benzinga Recap: Eagle Pharmaceuticals Q1 Earnings May 09, 2022 Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q1 earnings results on Monday, May 9, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Via Benzinga Perrigo Stock Mystery; Big Money Loves It, Though Profits Slim July 12, 2022 Institutional investors like mutual funds can't get enough of Perrigo stock. It has an A Accumulation/Distribution Rating. Via Investor's Business Daily Short Volatility Alert: Eagle Pharmaceuticals, Inc. June 15, 2022 On Tuesday, shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) experienced volatile short activity. After the activity, the stock price went up +2.39% to $43.35. The overall sentiment for EGRX has... Via Benzinga Eagle Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know May 04, 2022 Eagle Pharmaceuticals (NASDAQ:EGRX) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. Via Benzinga Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal March 28, 2022 Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has agreed to acquire Acacia Pharma Group plc Via Benzinga Eagle Pharma's Q4 Earnings Miss Street View On Lower Product Sales March 07, 2022 Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Q4 FY21 sales declined 15% Y/Y to $42.3 million, missing the consensus of $51.08 million. The sales declined primarily... Via Benzinga Eagle Pharmaceuticals: Q4 Earnings Insights March 07, 2022 Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q4 earnings results on Monday, March 7, 2022 at 06:50 AM. Here's what investors need to know about the announcement.... Via Benzinga Earnings Scheduled For March 7, 2022 March 07, 2022 Companies Reporting Before The Bell • Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million. •... Via Benzinga The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg March 06, 2022 Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... Via Benzinga Eagle Pharmaceuticals's Earnings Outlook March 04, 2022 Eagle Pharmaceuticals (NASDAQ:EGRX) is set to give its latest quarterly earnings report on Monday, 2022-03-07. Here's what investors need to know before the announcement. Analysts... Via Benzinga Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY™ February 01, 2022 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals on Track to Support Submission of New Drug Application in Second Quarter 2022 for Landiolol, a Beta-1 Adrenergic Blocker January 31, 2022 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin January 18, 2022 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals Provides 2022 Business Update and Announces Launch of Vasopressin January 05, 2022 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference January 03, 2022 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals Receives 180 Days of Marketing Exclusivity for Recently Approved Vasopressin December 29, 2021 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals Reports that Par Has Unilaterally Withdrawn Attempt to Halt Launch of Vasopressin December 20, 2021 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals Receives FDA Approval for Vasopressin December 15, 2021 From Eagle Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO December 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron... Via Benzinga The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More December 12, 2021 Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple... Via Benzinga Exposures Product Safety Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates December 02, 2021 A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for... Via Benzinga Exposures Product Safety Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 November 22, 2021 From Eagle Pharmaceuticals, Inc. Via Business Wire Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript November 09, 2021 EGRX earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Eagle Pharmaceuticals Reports Third Quarter 2021 Results November 09, 2021 From Eagle Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... Via Benzinga Eagle Pharmaceuticals to Host Third Quarter 2021 Financial Results on November 9, 2021 October 28, 2021 From Eagle Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.